HK1117529A1 - Organic compound and method for producing radioactive halogen-labeled organic compound using the same - Google Patents

Organic compound and method for producing radioactive halogen-labeled organic compound using the same

Info

Publication number
HK1117529A1
HK1117529A1 HK08108510.6A HK08108510A HK1117529A1 HK 1117529 A1 HK1117529 A1 HK 1117529A1 HK 08108510 A HK08108510 A HK 08108510A HK 1117529 A1 HK1117529 A1 HK 1117529A1
Authority
HK
Hong Kong
Prior art keywords
organic compound
radioactive halogen
amino
same
syn
Prior art date
Application number
HK08108510.6A
Other languages
English (en)
Inventor
Masahito Toyama
Fumie Kurosaki
Akio Hayashi
Osamu Ito
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of HK1117529A1 publication Critical patent/HK1117529A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0404Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK08108510.6A 2005-05-23 2008-08-01 Organic compound and method for producing radioactive halogen-labeled organic compound using the same HK1117529A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005149186 2005-05-23
PCT/JP2006/309643 WO2006126410A1 (ja) 2005-05-23 2006-05-15 新規有機化合物及び該化合物を利用した放射性ハロゲン標識有機化合物の製造方法

Publications (1)

Publication Number Publication Date
HK1117529A1 true HK1117529A1 (en) 2009-01-16

Family

ID=37451836

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108510.6A HK1117529A1 (en) 2005-05-23 2008-08-01 Organic compound and method for producing radioactive halogen-labeled organic compound using the same

Country Status (15)

Country Link
US (1) US7910745B2 (xx)
EP (1) EP1889834B1 (xx)
JP (1) JP4989467B2 (xx)
KR (1) KR101315152B1 (xx)
CN (1) CN101180272B (xx)
AT (1) ATE506347T1 (xx)
AU (1) AU2006250594B2 (xx)
CA (1) CA2608919C (xx)
DE (1) DE602006021418D1 (xx)
DK (1) DK1889834T3 (xx)
ES (1) ES2364463T3 (xx)
HK (1) HK1117529A1 (xx)
NO (1) NO20076411L (xx)
TW (1) TWI410396B (xx)
WO (1) WO2006126410A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007001958A2 (en) * 2005-06-23 2007-01-04 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
KR101643991B1 (ko) 2005-11-29 2016-07-29 니혼 메디피직스 가부시키가이샤 방사성 할로겐 표식 유기 화합물의 전구체 화합물
CN101563107B (zh) 2006-12-21 2012-07-11 日本医事物理股份有限公司 放射性诊断显像剂
EP2128130B1 (en) * 2006-12-27 2018-10-10 Nihon Medi-Physics Co., Ltd. Process for production of precursor compound for radioactive halogen-labeled organic compound
TWI406674B (zh) * 2007-02-13 2013-09-01 Nihon Mediphysics Co Ltd Method for manufacturing diagnostic radiographic diagnostic agents
JP5121349B2 (ja) * 2007-08-10 2013-01-16 株式会社トクヤマ アミノ酸の製造方法
KR20120034098A (ko) * 2009-07-11 2012-04-09 바이엘 파마 악티엔게젤샤프트 시클로알킬 기를 사용하는 방사성 표지 방법
JP2014501702A (ja) 2010-10-28 2014-01-23 ジーイー・ヘルスケア・リミテッド 放射性医薬品前駆体の安定化
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
JP7159157B2 (ja) * 2017-06-23 2022-10-24 日本メジフィジックス株式会社 放射性フッ素標識化合物の製造方法および放射性医薬の製造方法
CN110724058A (zh) * 2019-10-25 2020-01-24 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法
WO2021077424A1 (zh) * 2019-10-25 2021-04-29 吉林凯莱英制药有限公司 反式环丁烷邻二羧酸酯及其衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5808146A (en) 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
GB0229695D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids

Also Published As

Publication number Publication date
TWI410396B (zh) 2013-10-01
DK1889834T3 (da) 2011-08-08
EP1889834A1 (en) 2008-02-20
JP4989467B2 (ja) 2012-08-01
KR20080016557A (ko) 2008-02-21
JPWO2006126410A1 (ja) 2008-12-25
KR101315152B1 (ko) 2013-10-07
ES2364463T3 (es) 2011-09-02
US7910745B2 (en) 2011-03-22
CN101180272A (zh) 2008-05-14
AU2006250594B2 (en) 2011-06-16
TW200704630A (en) 2007-02-01
AU2006250594A1 (en) 2006-11-30
DE602006021418D1 (de) 2011-06-01
EP1889834B1 (en) 2011-04-20
WO2006126410A1 (ja) 2006-11-30
CA2608919A1 (en) 2006-11-30
CN101180272B (zh) 2012-04-25
EP1889834A4 (en) 2010-06-30
CA2608919C (en) 2012-11-20
ATE506347T1 (de) 2011-05-15
US20090105489A1 (en) 2009-04-23
NO20076411L (no) 2008-02-13

Similar Documents

Publication Publication Date Title
HK1117529A1 (en) Organic compound and method for producing radioactive halogen-labeled organic compound using the same
ATE550319T1 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
WO2007021858A3 (en) Methods of making radiolabeled tracers and precursors thereof
TNSN06451A1 (en) Radiation curable composition consisting of unsaturated amorphous polyesters and reactive dilutant agents
TNSN07132A1 (en) Radiation curable modified, unsaturated, amorphous polyesters
WO2008132964A1 (ja) 3,3,3-トリフルオロプロピンの製造方法
AR076027A1 (es) Metodos e intermediarios para la preparacion de agentes farmaceuticos
BRPI0507347B8 (xx)
PL2354235T3 (pl) Sposób fermentacyjnego wytwarzania L-aminokwasów z zastosowaniem bakterii maczugowatych
WO2010093182A3 (ko) L-아미노산 생산용 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법
BR0304632B1 (pt) composiÇço e processo para realÇar a produÇço de biomassa em estufas.
ZA200800065B (en) Method for producing radiation curable formulations with increased corrosion protection on metal substrates, and formulations of this type
WO2009102378A3 (en) Purification of 68ge/68ga generator eluate from fe(iii) intended to improve specific radioactivity of 68ga-based radiopharmaceuticals
GEP20135926B (en) Trazodone and trazodone hydrochloride in purified form
FR2930265B1 (fr) Procede d'agglomeration de poussieres industrielles, en particulier par technique de briquetage
MY146360A (en) Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof
IL187640A0 (en) Method for preparing clopidogrel and intermediates used therein
SV2008002512A (es) Derivados de aminoacidos ref. pc32769a
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
ATE533086T1 (de) Lichtempfindliche zusammensetzung und verfahren zur strukturformung damit
SG147336A1 (en) Cleaning process and apparatus
WO2008081635A1 (ja) 含窒素化合物の製造方法
EP2025663A4 (en) NOVEL CARBOXYLIC ACID COMPOUND, ITS APPLICATION AND METHOD OF PRODUCTION
BRPI0607968A2 (pt) método para preparar um composto de sulfóxido e composto de sulfóxido
ATE538102T1 (de) Verfahren zur herstellung eines chinazolinderivats

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220515